New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients – Read More

AlloMap HEART Logo

AlloMap gene expression profiling is used by over 90% of US transplant centers, and since approval has been used over 150,000 times in nearly 30,000 patients.

HeartCare Logo

HeartCare provides a comprehensive assessment of graft rejection by combining AlloMap Heart gene expression profiling with AlloSure® Heart dd-cfDNA


CareDx is continuing to innovate with new products and post-market approval studies